PURE Bioscience (OTCMKTS:PURE – Get Free Report) passed above its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $0.07 and traded as high as $0.07. PURE Bioscience shares last traded at $0.07, with a volume of 60,645 shares.
PURE Bioscience Stock Up 1.2%
The stock’s 50-day moving average price is $0.07 and its 200-day moving average price is $0.07. The company has a market capitalization of $11.05 million, a price-to-earnings ratio of -2.83 and a beta of 0.33.
PURE Bioscience Company Profile
PURE Bioscience, Inc develops and commercializes antimicrobial products based on its proprietary silver dihydrogen citrate (SDC) technology. The company’s formulations are designed to provide broad-spectrum antimicrobial activity while supporting applications where effective sanitation and surface treatment are required.
Its product portfolio has included disinfectants, sanitizers and antimicrobial solutions for hard-surface cleaning, food processing, healthcare, hospitality, institutional and commercial environments.
See Also
- Five stocks we like better than PURE Bioscience
- Skydance Just Became a Media Giant—With an $80 Billion Debt Load
- Could Velo3D Be the Next Defense Buyout Target?
- Penguin Solutions Is Soaring as AI Memory Demand Explodes
- Alphabet’s Chart Is Coiling—and the Fundamentals May Be Ready to Back It Up
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
